The NIMR Director General Prof Said S. Aboud through the NIMR-Mbeya Medical Research Centre hosted Dr. Eliud Wandwalo, the Head of TB, Global Fund in Geneva accompanied MKUTA CEO Dr Willy Mbawala. Salient discussions were held regarding the role of NIMR in contributing to country efforts regarding the End TB strategy by 2030 which is within the next 6 years. The institution was highly encouraged to take a bold move towards generating evidence for novel point of care tests for TB that are feasible within local settings as well as strengthening laboratory related aspects for improved TB diagnosis and management. It was also an opportunity to showcase varied studies funded by the Global Fund at @NIMRMbeya. These included studies focusing on modified shorter all oral MDR-TB treatment, COVID-19 impact on TB services delivery, HIV early infant diagnosis and Post TB Lung Disease. Grateful for the commitment to making a positive impact and fostering collaboration for a healthier world.